Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6789903 | Comprehensive Psychiatry | 2015 | 16 Pages |
Abstract
BD-migraine comorbidity may comprise of a sub-phenotype of BDs requiring patient-tailored therapeutic interventions to achieve an optimal outcome. Specifically, additional studies including longitudinal follow-up studies are aimed in order to shed further light on the actual prevalence rates and clinical features associated to BD-migraine comorbidity, with a special emphasis towards the clinically suggestive potential connection between mixed features, bipolar depression, migraine, and increased risk for suicidality. PROSPERO registration number: CRD42014009335.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Michele Fornaro, Domenico De Berardis, Concetta De Pasquale, Luisa Indelicato, Rocco Pollice, Alessandro Valchera, Giampaolo Perna, Felice Iasevoli, Carmine Tomasetti, Giovanni Martinotti, Ann Sarah Koshy, Ole Bernt Fasmer, Ketil Joachim Oedegaard,